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Abstract 
Background 
The relationship between procedural volume and prognosis after percutaneous coronary 
intervention (PCI) remains uncertain, with some studies finding in favor of an inverse 
association and some against. This UK study provides a contemporary reassessment in one 
of the few countries in the world with a nationally representative PCI registry. 
Methods and Results 
A nationwide cohort study was carried out using the national British Cardiovascular 
Intervention Society registry. All adult patients undergoing PCI in 93 English and Welsh NHS 
hospitals between 2007 and 2013 were analyzed using hierarchical modeling with 
adjustment for patient risk. Of 427,467 (22.0% primary PCI) procedures in 93 hospitals, 30-
day mortality was 1.9% (4.8% primary PCI). 87.1% of centers undertook between 200 and 
2000 procedures annually. Case mix varied with center volume. In centers with 200-399 PCI 
cases per year, a smaller proportion were PCI for STEMI (8.4%) than in centers with 1500-
1999 PCI cases per year (24.2%), but proportionally more were for STEMI with cardiogenic 
shock (8.4 vs. 4.3%). For the overall PCI cohort, after risk adjustment there was no 
significant evidence of worse, or better, outcomes in lower volume centers from our own 
study, or in combination with results from other studies. For primary PCI, there was also no 
evidence for increased or decreased mortality in lower volume centers. 
Conclusions 
Following adjustment for differences in case mix and clinical presentation, this study 
supports the conclusion of no trend for increased mortality in lower volume centers for PCI in 
the UK healthcare system. 
Clinical Trials Registration: https://clinicaltrials.gov/show/NCT02184949 
Keywords: angioplasty, percutaneous coronary intervention, mortality, volume, 
outcomes research  
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Introduction 
 
The relationship between procedural volume and patient outcomes is an important 
consideration in the provision of percutaneous coronary intervention (PCI). Studies that have 
suggested the existence of a relationship have informed international guidelines1-3 on the 
minimum procedural limits recommended for annual center volume to ensure safe and 
effective patient care. This is also reflected in recent UK guidance on the provision of PCI4. 
For acute myocardial infarction, the establishment of high throughput, high-volume Heart 
Attack Centers (HACs) within networks of acute cardiac care has been promoted as a factor 
contributing to the decline in cardiovascular mortality in developed healthcare systems5-9. 
Such centers often also have high volumes of elective PCI and in much of the published 
literature compare favorably with lower volume centers where higher rates of adverse 
outcomes, longer lengths of hospital stay and increased costs have been observed10-11. 
These findings have been reflected in the reconfiguration of UK PCI services over the past 
decade; specifically the expectation that lower volume units undertake at least 400 
procedures per annum. 
 
It is timely and of international importance to review the evidence for and against a 
relationship between PCI center volume and clinical outcomes in the UK healthcare system. 
Such a national review contributes to the assessment of the UK‟s quality improvement 
initiative in PCI and has implications for provision of service in other countries. A meta-
analysis of 10 studies (8 American, 2 Japanese, all prior to 2005) on PCI comprising 
1,322,342 patients in 1746 hospitals finds in favor of an inverse relationship between center 
volume and risk-adjusted in-hospital mortality after PCI (odds ratio 0.865 (95% CI 0.827 to 
0.905) for high vs. low volume center)12. However, evidence from studies published since the 
period covered by this meta-analysis have produced a more variable picture, with some 
studies supporting the presence of a relationship between center PCI volume and risk-
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adjusted outcomes10,11,13,14, and others not15-18. A more recent summary of the evidence by a 
joint task force from the American College of Cardiology Foundation, American Heart 
Association and American College of Physicians acknowledged that the large-scale studies 
in this area have produced heterogeneous findings19. Specifically in relation to primary PCI 
cohorts, a review by the National Clinical Guidance Centre20 likewise noted that the evidence 
base is currently insufficient to establish a definitive understanding of the volume-outcome 
relationship. 
 
In the United Kingdom (UK), continuous whole country data are collected through the British 
Cardiovascular Intervention Society (BCIS) registry of all PCI cases, are linked to the registry 
of deaths for all inhabitants in the UK collected independently by the Office for National 
Statistics and held by the National Institute for Cardiovascular Outcomes Research at 
University College London. This provides unique opportunities to understand outcomes after 
percutaneous interventions. We consequently used these mortality linked data to investigate 
the association between annual center volume of PCI cases and 30-day all-cause mortality 
over a seven year period up to 2013. 
 
 
 
Methods 
 
Setting and Design 
This observational prognostic cohort study was based on data from the BCIS national 
registry of adult interventional procedures, participation in which is mandated for all PCI 
operators and all National Health Service (NHS) Trusts in England and Wales. Data for 
every PCI procedure performed were collected at the time of procedure at each hospital. 
These data were then encrypted and transferred on-line to a central database at the National 
Institute for Cardiovascular Outcomes Research (NICOR), hosted at University College 
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London, UK. The data for each PCI procedure comprise 113 core fields which describe the 
patient demographics and clinical presentation, indications for PCI, procedural details and 
outcomes during the hospital stay21. NICOR, which includes BCIS (Ref: NIGB: ECC 1-06 
(d)/2011), has support under section 251 of the NHS Act 2006 to use anonymized patient 
information for medical research without consent. The study involved de-identified data and 
formal ethical approval was not required. 
 
Patients 
The sampling frame comprised all patients in England and Wales recorded in the BCIS 
database. Patients were eligible for analysis if they had received PCI to at least one lesion or 
vessel over a seven year period between 01 January 2007 and 31 December 2013, and 
were aged between 18 and 100 years. We excluded a total of 68,912 (11.7%) cases from 9 
private hospitals as they did not represent NHS care, and from 14 hospitals in Scotland and 
Northern Ireland as mortality tracking is only consistently available for patients with a NHS 
number in England and Wales. The exclusion of private hospitals was also to account for 
potential differences in clinical practice; typically they reflect independent operators rather 
than teams, and treat almost exclusively elective cases. An additional 11,871 (2.0%) cases 
from within English or Welsh NHS hospitals were also excluded because of missing 30-day 
mortality. Ventilated patients (who mainly present with out of hospital cardiac arrest) were 
also excluded as the risk adjustment model was inapplicable to such patients. For patients 
with multiple admissions, the earliest record was used with subsequent admissions being 
excluded. The final analytical cohort comprised 427,467 patients (Figure 1). Two subgroups 
were selected for analysis: (i) all PCI cases and (ii) only primary PCI cases. 
 
Patient characteristics were examined as part of an initial descriptive analysis, including 
indication for intervention, urgency of procedure (elective, urgent, emergency or salvage) 
and cardiogenic shock (based on clinical assessment including systolic blood pressure <100 
mmHg, pulse >100 bpm, in a patient who was cool, clammy or requiring inotropes, intra-
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cardiac balloon pump or cardiopulmonary support). 
 
Outcome 
Data for all-cause mortality were extracted through linkage to the Office for National 
Statistics using each patient‟s unique NHS number. Patients were followed-up for their vital 
status 30-days after the date of their PCI procedure. 
 
Centre Volume 
We took average center volume as the measure of the procedural volume exposure. 
Average center volume was determined for each center from its total number of PCIs 
registered in BCIS for the years 2007-13, divided by the number of years where PCI activity 
was non-zero. Records concerning pre-operatively ventilated patients, follow-up procedures 
and records with missing mortality outcome data were retained in the calculation of overall 
annual volume as these were deemed to contribute to the procedural volume. For the 
purpose of stratified analysis, bands of center average volume were established on the basis 
of existing standards and clinical experience. These bands were set at: 0-199, 200-399, 400-
749, 750-1499, 1500-1999 and ≥2000 cases. 
 
Case Mix Adjustment 
Model based case mix standardization for 30-day mortality outcome was performed to adjust 
for patient characteristics. The model22 was developed by an independent research group 
using data from the BCIS registry that comprised all eligible PCI records undertaken in 
England and Wales from 2007 through 2011. Clinical validation of the model subsequently 
undertaken by its developers showed that the model performed well in estimating risk for 
more recent cases. The model has 9 risk factors: age at time of procedure, sex, diabetes 
history, previous myocardial infarction, renal disease history, cerebrovascular event history, 
cardiogenic shock, indication for intervention and procedural urgency. These covariates 
7 
 
were selected for their clinical relevance, predictive utility, and low levels of missingness. 
The model includes interactions for age-diabetes, age-shock and indication-shock. We 
independently performed calibration and discrimination analyses to evaluate the model‟s 
suitability for our study (see supplementary materials). 
 
Statistical Analyses 
A statistical analysis plan was prepared and registered on www.clinicaltrials.gov prior to data 
analysis. Statistical analyses were performed using R version 3.1.2 (www.r-project.org) and 
Markov chain Monte Carlo software written in C++. Differences in baseline characteristics for 
average center volume bands were examined using analysis of variance for continuous 
variables and the chi-square test for categorical variables. All tests were two-tailed, and to 
correct for multiple comparisons, p-values were adjusted using the false discovery rate 
method23. 
 
Hierarchical logistic models for patient's 30-day mortality outcome nested in centers were 
applied to overall, and primary, PCI groups with adjustment for risk of adverse outcome. We 
included fixed effects for year of procedure to account for year by year change in risk-
adjusted outcomes, resulting in estimates of center level effects with 95% confidence 
intervals (CI). We computed the ratio of the probability of the estimated center level effects 
under the hypothesis of no relationship with volume to the probability of the effects under the 
hypothesis of a relationship. In the relationship hypothesis we took a uniform non-informative 
prior for the gradient with respect to log-volume. Details are provided in the Supplementary 
Materials. Each probability captures how well the effects estimates match each hypothesis, 
and the ratio makes a comparison. This ratio is akin to the likelihood ratio, and is called a 
„Bayes factor‟24. The smaller than 1 the Bayes factor is, the greater our effects estimates 
support the hypothesis of a relationship. We repeated these calculations for a band-specific 
relationship analysis, using the pre-specified volume bands as defined above. We also 
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estimated the gradient of center level effect to log-volume under the hypothesis of a 
relationship. 
 
Missing Data 
Records with missing mortality status (2.0%) were excluded as part of the sampling criteria 
(Figure 1). Hospital name and year of procedure were 100% complete. Missing data in 
covariates used to assign 30-day mortality risk were handled using the same method 
employed in the model‟s derivation: missing categorical covariates were set to their lowest 
risk value; missing age was set to sex-specific median values. This imputation technique 
ensured the model was implemented in line with its intended use in clinical practice. 
Additional detail on missing data is provided in the Supplementary Materials. 
 
Sensitivity Analyses 
To validate our results, we first examined whether the use of alternative estimation methods 
in the hierarchical modeling work impacted upon the coefficient estimates and confidence 
intervals. Second, to explore the categorization method used in the primary analyses, we 
performed an alternative analysis of the center volume-outcome relationship using equally 
sized quintiles of the mean annual number of cases of PCI per year. Third, we excluded the 
10% of patients who were in the top 30-day mortality risk decile (to correct for some over-
prediction of mortality identified in our calibration testing of the risk model). Fourth, we 
excluded the 5% of patients who had missing data for cardiogenic shock (to remove 
additional uncertainty about missing data as this field had the highest potential influence 
over mortality risk estimates derived from the risk model). Fifth, we repeated the model with 
elective only patients. Finally, for the primary PCI cohort we re-investigated the volume 
outcome relationship using each center‟s primary PCI mean annual volume rather than the 
volume of all PCIs undertaken at that center. 
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Results 
 
Baseline Characteristics 
Our analysis included 427,467 PCI procedures in 93 NHS hospitals in England and Wales, 
of which 94,022 (22.0%) were primary PCI. The mean (SD) age was 64.9 (11.9) and 26.5% 
were female (Table 1). Overall, 17.6% had diabetes, 1.4% had a creatinine greater than 200 
µmol/L, and of the primary PCI cohort (Table 2), 5.1% in total had cardiogenic shock. For the 
overall PCI cohort, 65.1% had a drug-eluting stent (DES) deployed, and 3.1% of the PCI 
procedures involved the use of intravascular ultrasound (IVUS) guidance. Among primary 
PCI patients, a smaller proportion of procedures involved IVUS use (1.5%), while 59.5% 
involved DES deployment. 
 
Tables 1 and 2 also show that the frequency of many patient and procedural characteristics 
differed between bands of center average volume. All characteristics were statistically 
significantly different between bands at p<0.001 for the overall cohort following false 
discovery rate adjustment for multiple comparison. Most were significant at the same 
threshold for the primary PCI cohort. Compared to the higher volume centers (≥2000), the 
lowest (0-199) volume centers had a smaller frequency of STEMI cases (2.8% in lowest vs. 
24.7% in highest), as well as PCI for NSTEMI (18.9 vs. 34.4%), but greater frequency of 
elective (53.3 vs. 38.5%), stable (47.9 vs. 37.1%) and rescue (22.3 vs. 1.4%) cases. The 
second lowest volume band (200-399) captures a much larger number of cases than the 
lowest band. Compared to the highest volume units, this second lowest volume band had a 
greater level of NSTEMI patients (52% in second lowest vs. 34.4% in highest) and of urgent 
cases (49.6% vs. 32.6%). 
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Although higher volume units handled a greater proportion of STEMI cases and had higher 
absolute levels of patients with cardiogenic shock, results for the primary PCI cohort (Table 
2) show that the second lowest volume units in that cohort had a higher proportion of 
patients with cardiogenic shock (8.4 vs. 3.7%) and of creatinine levels above 200 μmol/L 
(3.7 vs. 0.5%). Higher volume centers, on the other hand, had a greater proportion of 
primary PCI cases where the patient was a smoker (30.8 vs. 39%). 
 
For the total cohort, the crude unadjusted rate for mortality at 30-days was 1.9%. From 2007 
to 2013, the annual rate increased from 1.4% to 2.2%. By contrast, for primary PCI, the 
unadjusted 30-day mortality rate was 4.8% and remained unchanged in 2013 compared to 
2007. Across this same interval, predicted mortality rates increased from 1.3% to 2.3% in the 
overall PCI cohort, and from 4.8% to 5.2% for primary PCI cases.  
 
The median number of PCI cases treated annually per hospital was 659.5, and the mean 
was 878.5. The observed center average volumes ranged from 61 (almost always new 
centers starting up a PCI program) to 2794. Few centers (5.4%) undertook less than 200 
PCI procedures per year, with most (87.1%) performing on average between 200 and 2000 
procedures. Centre annual volumes increased over the study period from a mean of 889 in 
2007 to 917 in 2013. A smaller increase occurred for the primary PCI sample, from 934 to 
945 procedures per year. 
 
Volume and Mortality 
In both PCI and primary PCI groups, for 2007-13 in the UK, observed and predicted 30-day 
mortality rates depend on center average annual volume in a largely identical fashion 
(Figures 2 and 3). 
 
Risk-adjusted estimates of 30-day mortality for each center were derived through our 
hierarchical modeling. The dose-response relationship between volume and outcome was 
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estimated to be 1.04 (95% CI 1.01 to 1.07, P = 0.01) per 2-fold increase in center average 
annual volume. The Bayes factor was 0.14 meaning that, taking into account the center level 
effects, the ratio of the chance that there is no volume-outcome relationship compared to the 
chance that there is such a relationship is increased by a factor of 0.14. Our summary of 
existing literature yielded a prior chance of a relationship of 0.5 (denoting equal chances of 
the relationship being absent or present). The current study's center-level effect estimates 
revise this down to 0.12. That is to say, the prior probability is adjusted in light of the 
evidence from our data. Thus there remains support, with probability greater than 0.05, for 
the hypothesis that there is no volume outcome relationship in our overall PCI cohort. 
 
We also examined each of the pre-specified volume bands in our overall PCI cohort. Bayes 
factors for the hypothesis that a band-specific effect is absent relative to the hypothesis that 
it is present are reported in Table 3. Bands 0-199, 200-399 and 1500-1999 have Bayes 
factors less than 1, signifying that the hypothesis of no band-specific effect is less plausible25 
in the light of the center level effects for these bands. However, repeating the argument of 
the previous paragraph, under the assumption of a 0.50 prior chance of no band-specific 
effect, the chance of the band with the smallest Bayes factor, 1500-1999, having no effect is 
revised down to 0.12, i.e. there remains support, greater than 0.05, for the hypothesis that 
there is no band-specific effect for this, or any other, band. 
 
In the primary PCI subset of cases, the dose-response relationship of volume outcome was 
estimated to be 1.01 (95% CI 0.99 to 1.04, p-value = 0.36) per 2-fold increase in center 
average annual volume. The Bayes factor was 1.4 meaning that the ratio of the chance of a 
volume-outcome relationship for primary PCI compared to the chance of no volume outcome 
relationship is increased by a factor of 1.4. Taking the before study chances of no 
relationship to be 0.50, our center level effects revise the chance up to 0.74, providing 
support, with probability greater than 0.05, for the hypothesis that there is no volume 
outcome relationship in the primary PCI cohort. For each pre-specified volume band in this 
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cohort, Table 3 also reports a Bayes factor for the hypothesis that there is a band-specific 
volume outcome effect relative to a hypothesis that there is not. Band 1500-1999 has a 
Bayes factor less than 1 signifying that the hypothesis of no band-specific effect is less 
plausible in light of the center level effects within that band. Under the assumption of a 0.50 
prior chance of no 1500-1999 band-specific effect, the chance is revised down to 0.41, i.e. 
there again remains significant support for the hypothesis that there is no band-specific 
effect for this, or any other, band. 
 
Sensitivity Analyses 
We found very good agreement in center level effects between the MCMC and R 
estimations. Modest differences in uncertainties for center level effects between MCMC and 
R were identified but these were insufficient to alter our conclusions. The stratified analyses 
were replicated using quintiles of center average volume and the results showed clear 
similarity to our existing findings for both total PCI cases and primary PCI cases. Full details 
are provided in the supplemental materials. Notably, there was less variation in the lowest 
volume quintiles for both the overall and primary PCI volumes compared to their equivalent 
clinically based counterparts (Figures 2 and 3), which is likely indicative of the more evenly 
distributed volume sizes. When only centers‟ volumes of primary PCI cases (rather than their 
overall PCI volumes) were considered, we found no significant association between volume 
of primary PCI cases and risk of 30-day mortality. The exclusion of the 10% of patients who 
were in the top 30-day mortality risk decile, and separately the exclusion of the 5% of 
patients who had missing data for cardiogenic shock, did not change the overall finding 
regarding center volume-outcome relationship. A similar affirmation of the hierarchical 
findings was obtained for the elective-only cases and with the primary PCI cohort. 
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Discussion 
 
This is the first whole–country, consecutive series patient-level analysis of the relationship 
between total center volume of PCI cases and risk-adjusted mortality at 30-days, undertaken 
using contemporary clinical data within a modern health care system. For the overall PCI 
cohort, the evidence for a trend between center average annual volume and risk-adjusted 
30-day mortality was not sufficient to conclude the presence of a relationship in the context 
of a priori evidence. For the primary PCI subset of cases, no evidence was found for a 
relationship between center average annual volume and risk-adjusted 30-day mortality. 
 
The findings are consistent with earlier studies that have found no evidence of a relationship 
between PCI volume and risk-adjusted mortality outcomes16-18,26,27. Although many other 
existing studies have argued in favor of higher-volume centers, the importance of adjustment 
for case selection and hospital effects cannot be understated. One of the largest studies to 
date15 found that whilst crude mortality estimates increased exponentially at lower volume 
institutions, there was no relationship between hospital volume and mortality after 
consideration of confounding factors. 
 
The current study has additionally demonstrated the utility of Bayes factors, which can be 
computed as a guide to the weight of evidence in studies where alternative hypotheses are 
being evaluated, in contrast to p-values which only measure how extreme a test statistic 
derived from a study's data is under one hypothesis alone. In this study, their use enabled 
comparison of the evidence for the contrasting hypotheses that a relationship between 
volume and center effects is either absent or present. Bayes factors usefully enable the 
interpretation of study data in combination with a priori evidence24. Following the principles of 
Bayesian inference, we combined our study's Bayes factors with existing findings from 
comparable observational studies, with final results showing that, under the current UK PCI 
regimen, the evidence does not challenge a prior assumption which places reasonable 
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probability on no volume-outcome relationship. This Bayesian approach is a general one, 
with applicability beyond both the clinical context and observational design used in the 
present study. 
 
We have identified important differences in the baseline cardiovascular risk and presenting 
phenotype between lower and higher volume centers. For example, we found that smaller 
centers had fewer patients with STEMI indications. However, STEMI cases handled at low 
volume centers were proportionally more likely to present with cardiogenic shock – a 
particularly influential factor in patient survival, as is empirically reflected by its high 
weighting in the risk adjustment model used in this work22. Since the risk adjustment 
accounted for these characteristics, it may be argued that there is evidence for a volume-
dependent case selection bias which attenuates the relationship between center volume and 
mortality. A similar phenomenon has been observed in CABG research28 but we can only 
speculate as to why this may be occurring. It may reflect that such cases are undertaken 
emergently at the presenting hospital if the risk of transfer to a specialist Heart Attack Centre 
(HAC) is deemed too high, or that Emergency Medical Services bring the sickest patients to 
the closest hospital. It may also reflect a different clinical approach to the definition of 
cardiogenic shock in lower volume centers. An alternative interpretation may be that higher 
volume centers are more selective in their choice of primary PCI cases. These possibilities 
warrant further inquiry, particularly given that recent work has shown that center volume of 
patients with cardiogenic shock is associated with improved patient outcomes29. 
 
It is important to consider wider contextual issues regarding clinical practice and policy in 
understanding the results we have established in this study. The UK has accommodated 
current international guidance with national recommendations that discourage low volume 
centers with consistently <400 PCI cases per annum and encourage regular practice with a 
minimum annual operator activity of >75 cases per year4. This may, in part, account for the 
absence of evidence for a center-volume outcome relationship. In many parts of the UK, 
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operators in lower volume centers also have PCI sessions in the regional higher volume 
centers, thus increasing their individual annual experience and allowing greater opportunity 
to select more complex cases to be performed at a higher volume regional center. 
 
The development of new dedicated HACs as well as changes in individual practice have 
been associated with considerable expansion in the provision of PCI within the UK over the 
past decade –the current study‟s findings reflect these developments. It has meant that our 
study captures a section of the volume spectrum beyond that typically captured in prior 
research. The term “low volume” is context specific and varies between research settings. 
Many studies have used coarse volume categorizations that arguably lack measurement 
precision and make comparisons between research findings and clinical settings difficult17,18. 
In this study we explored volume using diverse strategies such as existing recommended 
volume thresholds, data-driven quantiles, and cohort-specific volume definitions (i.e. primary 
PCI case volume alone). This provides a detailed insight into the volume-outcome 
relationship, but does not overcome the fact that the range of volumes captured in this work 
may differ from previous studies. Consequently, while the current study has provided 
evidence that the relationship between hospital volumes and patient mortality is mitigated 
when adjustment is made for case mix, inferences should not be made regarding particularly 
low volumes not captured by this study. We cannot exclude the existence of a lower volume 
limit below which institutional competence cannot be assured. Rather, the findings suggest 
that the efforts made within the UK NHS to improve access to PCI and provide guidance for 
institutional standards of service provision have resulted in a uniformly high standard of care. 
We do not argue against the promotion of volume thresholds, given that its adoption has 
been a key aspect of the expansion of PCI provision in the UK. The policy whereby the acute 
management of STEMI is restricted to a limited number of dedicated HACs is driven largely 
by logistical necessity, and is not challenged by this study‟s findings. 
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Strengths and Limitations 
The strengths of this study include the national data source of consecutive PCI cases, the 
depth of detail of clinical data and the robust mortality tracking and linkage. The findings of 
this work are also based on strong methodological foundations. More commonly employed 
fixed-effect regression methods would not have reflected the hierarchical nature of the data 
under investigation30, namely the nesting of procedural results within centers. Hierarchical 
models were employed in this study to estimate center-level effects independently of center 
average volume, which were analyzed using Bayes factors to assess evidence for, and 
against, a relationship between volume and risk-adjusted outcome. Nonetheless, there are 
limitations to our study. These include the categorization of the center volumes using clinical 
consensus and existing guidelines. To address this limitation we also modeled volume as a 
continuous variable and undertook sensitivity analyses using quintiles of volumes; each 
method supported our main study findings and provided verification that our results were not 
the consequence of the a priori clinical categorization. Whilst BCIS data collection is 
mandated for all operators and all cases in England and Wales, it is possible that some 
cases will not have been recorded, though such omissions are likely to be minimal, as case 
ascertainment has been shown to be 100% for the majority of NHS hospitals in England and 
Wales31. Further, some of the cases had missing data which we treated in an identical 
manner to the way in which the risk model was derived. Multiple imputation may have 
allowed more cases to be modeled and with different precision32. However, sensitivity 
analyses showed that excluding records missing data in the highest weighted risk factor 
made no difference to our conclusions. Operator identifying data were not collected reliably 
by the BCIS registry until 2012, and so consultant volumes were not addressed in this study. 
While our research has not supported the presence of a relationship between center volume 
and outcomes, existing research33 suggests that valuable additional insights will be obtained 
once sufficient data is available to replicate the current study at the consultant-level. Finally, 
due to the observational nature of data, the models produced in this work disclosed many 
important associations, but cannot provide evidence for causation. However, it would not 
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have been possible to obtain such coverage of real-world practice as achieved in this work if 
an experimental design had been employed34,35. 
 
Conclusions 
Data covering all cases of emergent and elective PCI in England and Wales has shown that 
most centers undertake between 200 and 2000 PCI procedures per year on average. Lower 
volume centers undertake proportionally less STEMI cases overall but proportionally more 
high risk primary PCI than higher volumes centers. Whilst observed and predicted mortality 
rates depend on annual center volume, we have found that once adjustment is made for 
patient case mix, there is insufficient evidence for a credible volume-outcome relationship for 
PCI. Our analysis suggests that the current configuration of PCI services in England and 
Wales delivers care of uniformly high quality. 
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Table 1. Patient and procedural characteristics for all PCI cases categorised by mean annual overall PCI volumes 
 MEAN ANNUAL OVERALL PCI VOLUME CATEGORIES 
Total  0-199 200-399 400-749 750-1499 1500-1999 ≥2000 
Hospital (count)* 5 26 24 23 8 7 93 
Annual overall PCI volume (range 
of hospital means)* 
61-155 203-391 403-747 759-1457 1526-1728 2016-2794 61-2794 
Overall PCI procedures (count)* 2588 37133 67510 148751 76370 95115 427467 
        
PATIENT CHARACTERISTICS        
Age in years(Mean±SD)* 64.9+/-11.4 65.4+/-11.7 65.6+/-11.8 65.0+/-11.9 63.9+/-11.7 64.8+/-12.0 64.9+/-11.9 
Female* 675(26.1) 10076(27.1) 17799(26.4) 38618(26) 20243(26.5) 25861(27.2) 113272(26.5) 
Diabetes* 251(9.7) 5890(15.9) 12589(18.6) 27218(18.3) 12606(16.5) 16779(17.6) 75333(17.6) 
Hypertension* 1505(58.2) 17682(47.6) 31655(46.9) 80553(54.2) 37411(49) 45395(47.7) 214201(50.1) 
Hypercholesterolemia* 1559(60.2) 16535(44.5) 32790(48.6) 88195(59.3) 40920(53.6) 44434(46.7) 224433(52.5) 
Family history of coronary artery 
disease* 
1037(40.1) 15351(41.3) 24273(36.0) 56444(37.9) 29401(38.5) 37260(39.2) 163766(38.3) 
Current smoking* 415(16.0) 7889(21.2) 13271(19.7) 34834(23.4) 18864(24.7) 21979(23.1) 97252(22.8) 
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Previous MI* 505(19.5) 8147(21.9) 13298(19.7) 29954(20.1) 14034(18.4) 21241(22.3) 87179(20.4) 
Previous CVA* 38(1.5) 1232(3.3) 2300(3.4) 5614(3.8) 2916(3.8) 3782(4.0) 15882(3.7) 
Previous PCI* 484(18.7) 5214(14.0) 8526(12.6) 17926(12.1) 7988(10.5) 10120(10.6) 50258(11.8) 
Renal Disease:        
    Creatinine>200 μmol* 19(0.7) 641(1.7) 971(1.4) 2418(1.6) 964(1.3) 1037(1.1) 6050(1.4) 
    Acute or chronic* 9(0.3) 137(0.4) 666(1.0) 1108(0.7) 823(1.1) 485(0.5) 3228(0.8) 
        
PRESENTATION        
Indication:        
    Stable* 1240(47.9) 14238(38.3) 24816(36.8) 51230(34.4) 25310(33.1) 35310(37.1) 152144(35.6) 
    NSTEMI* 489(18.9) 19314(52.0) 28223(41.8) 56866(38.2) 30007(39.3) 32688(34.4) 167587(39.2) 
    STEMI* 73(2.8) 3110(8.4) 12057(17.9) 37169(25) 18464(24.2) 23514(24.7) 94387(22.1) 
    Rescue* 578(22.3) 336(0.9) 852(1.3) 2896(1.9) 2101(2.8) 1342(1.4) 8105(1.9) 
Shock* 21(0.8) 519(1.4) 1113(1.6) 2867(1.9) 1204(1.6) 1182(1.2) 6906(1.6) 
Urgency        
    Elective* 1380(53.3) 14240(38.3) 25419(37.7) 51401(34.6) 25527(33.4) 36665(38.5) 154632(36.2) 
    Urgent* 524(20.2) 18424(49.6) 27294(40.4) 52782(35.5) 28018(36.7) 30984(32.6) 158026(37) 
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    Emergency* 683(26.4) 4291(11.6) 14593(21.6) 44174(29.7) 22450(29.4) 27391(28.8) 113582(26.6) 
    Salvage* 0(0.0) 33(0.1) 108(0.2) 357(0.2) 217(0.3) 39(0.04) 754(0.2) 
        
PROCEDURAL 
CHARACTERISTICS 
       
Multiple vessels attempted* 559(21.6) 6518(17.6) 12246(18.1) 26902(18.1) 14151(18.5) 20461(21.5) 80837(18.9) 
Stent deployed* 2491(96.3) 34679(93.4) 63098(93.5) 137430(92.4) 70510(92.3) 85196(89.6) 393404(92) 
DES deployed* 1835(70.9) 25939(69.9) 45183(66.9) 98385(66.1) 50995(66.8) 60777(63.9) 283114(66.2) 
IVUS use* 31(1.2) 779(2.1) 1605(2.4) 5123(3.4) 2499(3.3) 3080(3.2) 13117(3.1) 
UPLMS(where LMS attempted)* 19(79.2) 457(70.4) 1007(69.5) 3179(70.1) 1501(62.7) 2527(79.5) 8690(71.1) 
 
*=Significant between-volume category difference at p<0.001 
SD=standard deviation; MI=myocardial infarction; CVA=cerebral vascular accident; PCI=percutaneous coronary intervention; NSTEMI=non-ST 
segment elevation myocardial infarction; STEMI=ST-segment elevation myocardial infarction; DES=drug-eluting stent; IVUS=intravascular 
ultrasound; (UP)LMS=(unprotected) left main stem 
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Table 2. Patient and procedural characteristics for primary PCI cases categorised by mean annual overall PCI volumes. 
 
 MEAN ANNUAL OVERALL PCI VOLUME CATEGORIES 
Total  0-199 200-399 400-749 750-1499 1500-1999 ≥2000 
Hospitals (count)* 4 26 23 23 8 7 91 
Annual overall PCI volume (range 
of hospital means)* 
142-155 203-391 403-747 759-1457 1526-1728 2016-27941 142-2794 
Primary PCI procedures (count)* 69 3075 11993 37058 18386 23441 94022 
        
PATIENT CHARACTERISTICS        
Age in years(Mean±SD)* 65.8+/-12.7 65.9+/-13.3 64.1+/-13.1 63.7+/-13.1 63.0+/-12.9 63.2+/-13.1 63.8+/-13.1 
Female* 20(29.0) 847(27.5) 3048(25.4) 9385(25.3) 4840(26.3) 6307(26.9) 24447(26.0) 
Diabetes* 4(5.8) 365(11.9) 1547(12.9) 5019(13.5) 2218(12.1) 2939(12.5) 12092(12.9) 
Hypertension* 27(39.1) 1047(34) 4093(34.1) 15681(42.3) 6986(38.0) 8600(36.7) 36434(38.8) 
Hypercholesterolemia* 21(30.4) 793(25.8) 3538(29.5) 16070(43.4) 7230(39.3) 7932(33.8) 35584(37.8) 
Family history of coronary artery 
disease* 
13(18.8) 964(31.3) 3441(28.7) 11540(31.1) 5623(30.6) 7842(33.5) 29423(31.3) 
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Current smoking* 20(29.0) 946(30.8) 3870(32.3) 13570(36.6) 6597(35.9) 9146(39) 34149(36.3) 
Previous MI* 8(11.6) 356(11.6) 1113(9.3) 3644(9.8) 1854(10.1) 2428(10.4) 9403(10.0) 
Previous CVA† 2(2.9) 82(2.7) 371(3.1) 1360(3.7) 693(3.8) 789(3.4) 3297(3.5) 
Previous PCI* 4(5.8) 222(7.2) 711(5.9) 2380(6.4) 1025(5.6) 1168(5.0) 551(5.9) 
Renal Disease*        
    Creatinine>200 μmol* 1(1.4) 114(3.7) 121(1.0) 327(0.9) 141(0.8) 127(0.5) 831(0.9) 
    Acute or chronic* 0(0.0) 11(0.4) 74(0.6) 147(0.4) 73(0.4) 68(0.3) 373(0.4) 
        
PRESENTATION        
Indication STEMI 69(100) 3075(100) 11993(100) 37058(100) 18386(100) 23441(100) 94022(100) 
Shock* 6(8.7) 258(8.4) 789(6.6) 2043(5.5) 786(4.3) 870(3.7) 4752(5.1) 
Urgency:        
    Emergency* 69(100) 3064(99.6) 11938(99.5) 36967(99.8) 18342(99.8) 23427(99.9) 93807(99.8) 
    Salvage* 0(0.0) 11(0.4) 55(0.5) 91(0.2) 44(0.2) 14(0.1) 215(0.2) 
        
PROCEDURAL 
CHARACTERISTICS 
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Multiple vessels attempted* 10(14.5) 359(11.7) 1122(9.4) 3052(8.2) 1825(9.9) 2340(10.0) 8708(9.3) 
Stent deployed* 64(92.8) 2892(94.0) 11371(94.8) 34585(93.3) 17084(92.9) 21985(93.8) 87981(93.6) 
DES deployed* 38(55.1) 1908(62.0) 7278(60.7) 22270(60.1) 11797(64.2) 13955(59.5) 57246(60.9) 
IVUS use 0(0.0) 40(1.3) 149(1.2) 552(1.5) 307(1.7) 353(1.5) 1401(1.5) 
UPLMS(where LMS attempted)* 0(100) 50(98.0) 162(88.0) 482(66.7) 228(70.2) 361(81.1) 1283(74.2) 
 
*=Significant between-volume category difference at p<0.001, 
†=Significant between-volume category difference at p<0.05 
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Table 3. Bayes’ factors for stratified analysis for all PCI cases and primary PCI cases categorised by mean annual overall PCI volumes 
 
 MEAN ANNUAL OVERALL PCI VOLUME CATEGORIES 
 0-199 200-399 400-749 750-1499 1500-1999 ≥2000 
All PCI 0.92 0.58 2.40 4.30 0.18 2.28 
       
Primary PCI 1.78 4.68 5.40 5.44 0.70 3.49 
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Figure Titles/Legends 
 
Figure 1. Data flow from sampling frame to analytical cohort. 
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Figure 2. Observed and predicted mortality and relative risk of mortality by mean annual 
center volume: All PCI cases 
Legend: 
Scatterpoints: Hospital-level estimates (with 95% CI bars for relative risk) 
Colored panes: Linear estimates of mortality risk for each volume band, with 95% CI 
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Figure 3. Observed and predicted mortality and relative risk of mortality by mean annual 
center volume: Primary PCI cases 
Legend: 
Scatterpoints: Hospital-level estimates (with 95% CI bars for relative risk) 
Colored panes: Linear estimates of mortality risk for each volume band, with 95% CI 
 
